This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China's Fujian Province issues negative list on data outflows

( December 26, 2025, 08:27 GMT | Official Statement) -- MLex Summary: Authorities in southeastern Fujian have rolled out a negative list governing data outflows in its free trade zone. The document identifies important data and personal information categories in the pharmaceutical, connected vehicle and aircraft maintenance sectors that require security clearances for export, clarifying corresponding settings, data characteristic and descriptions. It also establishes thresholds for personal data in the retail sector’s membership-management setting, setting a benchmark for exports needing security review. The negative list also clarifies the thresholds of personal data in select settings across these sectors whose transfers must proceed either via standardized contract filings or by securing a personal-information protection certification. The statement follows and the negative list is attached (both in Chinese). ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections